科前生物：关于获批新兽药注册证书的自愿性信息披露公告

Core Viewpoint - The announcement by Keqian Bio regarding the approval of its inactivated vaccine for porcine Seneca virus disease (HB16 strain) as a new veterinary drug by the Ministry of Agriculture and Rural Affairs of the People's Republic of China [1] Group 1 - Keqian Bio has received approval for its inactivated vaccine for porcine Seneca virus disease, which is a significant development for the company [1] - The approval was granted in accordance with the Veterinary Drug Management Regulations and the Veterinary Drug Registration Measures [1] - The company has been issued a New Veterinary Drug Registration Certificate following the review by the relevant authorities [1]